Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Stroke: secondary prevention].
Gubitz G, Lip G, Sudlow C, Sandercock P. Gubitz G, et al. Vasa. 2004 May;33(2):110-3; discussion 114. doi: 10.1024/0301-1526.33.2.110. Vasa. 2004. PMID: 15224467 Review. German. No abstract available.
[Stroke: management].
Gubitz G, Sandercock P, Warburton E. Gubitz G, et al. Vasa. 2004 Feb;33(1):55-7; discussion 57-8. doi: 10.1024/0301-1526.33.1.55. Vasa. 2004. PMID: 15061051 German. No abstract available.
Stroke prevention.
Sudlow C, Gubitz G, Sandercock P, Lip G. Sudlow C, et al. Among authors: gubitz g. Clin Evid. 2002 Jun;(7):175-98. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):184-208. PMID: 12230643 Updated. Review. No abstract available.
Stroke prevention.
Sudlow C, Gubitz G, Sandercock P, Lip G. Sudlow C, et al. Among authors: gubitz g. Clin Evid. 2002 Dec;(8):184-208. Clin Evid. 2002. Update in: Clin Evid. 2003 Dec;(10):246-72. PMID: 12603877 Updated. Review. No abstract available.
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Among authors: gubitz g. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.
Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group. Mair G, et al. Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9. Neurology. 2016. PMID: 26658907 Free PMC article. Clinical Trial.
EPITHET--where next?
Sandercock P, Wardlaw J, Dennis M, Lindley R, Hankey G, Matz K, Peeters A, Phillips S, Gubitz G, Prasad K, Ricci S, Celani MG, Righetti E, Cantisani T, Arauz A, Berge E, Slot KB, Kobayashi A, Czlonkowska A, Correia M, Murray V, Lyrer P, Venables G; IST-3 Collaborative Group. Sandercock P, et al. Among authors: gubitz g. Lancet Neurol. 2008 Jul;7(7):570-1; author reply 571-3. doi: 10.1016/S1474-4422(08)70123-6. Lancet Neurol. 2008. PMID: 18565447 No abstract available.
245 results